Dr. Donald Russell Locke, MD

Dr. Locke practices at HCA Florida West Marion Hospital, a Part of HCA Florida Ocala Hospital in Ocala, Florida.

Dr. Locke's NPI, 1497703912, was assigned on May 5, 2006. Dr. Locke graduated from University Of Florida College Of Medicine in 1983. Dr. Locke holds Florida license ME44759.

Dr. Locke's primary practice is HCA Florida West Marion Hospital, a Part of HCA Florida Ocala Hospital, at 4600 Sw 46th Ct, Ocala, FL 34474 in Marion County. The practice phone is (352) 291-6401.

Dr. Locke's primary practice is HCA Florida West Marion Hospital, a Part of HCA Florida Ocala Hospital in Ocala, Florida. The medical group on file is Vantage Urologic Institute. Dmand AI also links Dr. Locke to 1 more group practice or clinic, 1 ambulatory surgery center and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Locke practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Locke's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Locke is board certified in urology by the American Board of Urology. Dmand AI has Dr. Locke's licenses on file in 8 states: Florida, Arizona, Colorado, California, North Carolina, New York, Oregon and Georgia.

Dmand AI lists bladder disease, enlarged prostate, erectile dysfunction, prostate cancer, prostate inflammation or infection, testicular dysfunction, urinary endoscopy and UTI among the conditions Dr. Locke treats.

CMS data shows 1,482 Medicare services from Dr. Locke across 17 procedure codes in 2024, for 211 Medicare patients. Medicare paid $65,088 for them. Every service was in an office.

CMS counts 211 Medicare patients who saw Dr. Locke in 2024. The largest group is 75 to 84, with 104 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Locke's median patient age at 70, with 8% women.

In 2024, Dr. Locke wrote 428 Medicare Part D claims for 122 patients. 93% of them were for generic drugs. CMS names the drug for 342 of them, across 10 drugs with 11 or more claims each, at $199,792 in total drug cost. In 2023, CMS named 313 claims across 7 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Locke for performance year 2024, reported as part of a group. Dr. Locke accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 33 general payments to Dr. Locke from 12 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 55% of the total. NeoTract Inc. paid the most, $729.

Dmand AI lists 1 award for Dr. Locke.

Dr. Locke graduated from University Of Florida College Of Medicine in 1983. Dr. Locke is a member of ACS.

Dr. Locke is in network with 10 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.